CervoMed Inc. rose 29.2% on Wednesday, November 11, 2026, on 9,990,700 shares, 21 times its average daily volume. No headline about CRVO came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
CervoMed Inc. (CRVO:NASDAQ) closed at $1.69 on November 13, 2026, down 7.65% on the day. The stock trades 83.1% below its 52-week high of $10.00 and 33.1% above its 52-week low of $1.27. Over the past year, it lost 79.4%. CervoMed Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, CRVO closed higher on 102 days (40%). Its best day was June 16, 2026 (+82.26%) and its worst was June 10, 2026 (-22.15%). The stock moved 10% or more in a single session 15 times. It opened at least 5% above the previous day's high 2 times.
Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer.
Find more stocks like CRVO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.